ERBB2 and breast carcinoma: Furthermore, a significant association was found between cats with HER2-overexpressing mammary carcinomas (luminal B-like and HER2+ subtypes) and cats with high serum SDF-1 levels, as reported for breast cancer patients [40, 43].